PARK7 and Parkinson disease: Park2, Park7 and Pink1 stand out among Parkinson’s disease-specific genes downregulated by both treatments, since they are involved in biological processes characteristic of this disease, like dopamine uptake and neurotransmission, autophagy and degradation of mitochondria.